鶹Ʒ

Chapter 3

Conclusions

Chapter 1 summarized life expectancy and mortality in the Americas between 2000 and 2019 for three broad groups of conditions: communicable, maternal, perinatal, and nutritional conditions (CMPN), noncommunicable diseases (NCDs), and external causes (also known as injuries from unintentional and intentional causes). Comparisons were made with other WHO regions, and summaries were presented separately for women and men, across broad age groups (under 5s, 5–19 years, 20–39 years, 40–64 years, 65 years and older), and for each of the eight subregions of the Americas.

Chapter 2 focused on mortality and disability in the Americas between 2000 and 2019 for six groups of conditions: cardiovascular diseases, cancers, respiratory diseases, diabetes, mental and substance use disorders and neurological conditions, and external causes. Together in 2019, these six groups of conditions accounted for three-quarters (77%) of all deaths and two-thirds (63%) of all disability (measured using disability-adjusted life years, DALYs) in the Americas. The chapter focused on leading individual causes from each group of conditions, so that the report explored the changing regional burden of 33 leading causes of death and disability. After a general introduction to these leading causes, the chapter reviewed each of the six groups in turn, presenting changes since 2000, age-related change, and regional inequalities by gender and between countries.

The first two chapters provided a large amount of comparative information, for use partly as a reference resource on the changing disease burden in the Americas since the turn of the century. For readers with limited time, in Chapter 1, section 1.3 summarizes the information on regional life expectancy and regional mortality. In Chapter 2, the key messages are summarized in section 2.8: on six grouped causes of NCD deaths (cardiovascular diseases, cancers, respiratory diseases, diabetes, mental and substance use disorders and neurological conditions, and external causes), on 57 individual causes of NCD deaths, and on each of the six grouped NCD causes.

This final chapter draws on the evidence from earlier chapters to describe emerging themes relevant to the region. There are five themed stories, and for each there is a summary list of key points, one or more descriptive graphics, and several paragraphs that use the graphics to describe the emerging theme. The themes are as follows:

Theme 1. Improving NCD mortality rates lead to increased life expectancy across the Americas.

Theme 2. Population growth and rapid aging have fueled a rise in the number of NCD deaths.

Theme 3. There are important NCD mortality rate inequalities across the Region.

Theme 4. Men have had consistently higher rates of NCD death and disability since 2000.

Theme 5. The Caribbean subregions are disproportionately affected by cardiovascular disease, cancers, and diabetes.

These themes do not represent an exhaustive description of how the emerging NCD burden is affecting the region, but they each represent an important issue emerging from the evidence in this report. Each theme is broad in scope, with economic and social and as well as health consequences.

Theme 1. Improving mortality rates lead to increased life expectancy across the Americas

  • Life expectancy at birth in the Americas in 2019 was 77.2 years, up from 74.1 years in 2000 and exceeding the global average by 3.9 years. Life expectancy among adults aged 60 years was 22.7 years in 2019, up from 21.1 years in 2000.
  • This increased life expectancy has been driven by 20-year improvements in many of the region’s leading causes of death.
  • Considering the leading 10 causes of death (see figure 11) the mortality rates for nine of these have fallen, and only the mortality rate from Alzheimer and other dementias has increased.
  • There were 33 leading causes of death and disability covered by this report, 29 of which had associated mortality. The mortality rate for 20 of these leading causes improved between 2000 and 2019.
  • The combined mortality rate improvement among these 20 causes of death was 105 deaths per 100 000, compared to a combined mortality rate increase of 21 per 100 000 among the 9 causes with mortality rate increases.
  • Figure 26 summarizes the mortality rate change between 2000 and 2019 for 29 of 33 leading causes of death with associated mortality.13 Mortality rates for 20 out of 29 causes improved,contributing to the regional improvement in life expectancy. This progress reflects important healthcare advances across the Region, along with public health communication successes.

    Particularly large reductions in the mortality rates of ischemic heart disease and stroke led this 20-year mortality rate reduction. The success in reducing CVD mortality rates can be partly ascribed to reductions in smoking rates, improvements in the capacity to control high cholesterol and blood pressure, and in particular, greater access to effective care in the event of a heart attack or stroke (22).

    These successes lead to regional aging, which generates new challenges, including more healthcare demand. The complexity of health care is also set to increase, with multimorbidity likely to become a key challenge for healthcare providers. In the face of increasing and increasingly complex healthcare demand, the move toward universal health coverage (UHC) – with an ultimate goal of maintaining health and avoiding risk factors for all – is an aspirational target for most regional governments. The definition of UHC includes three related dimensions: unfettered access to health services, financial protection when faced with health care, and quality healthcare provision that is also cost-effective and sustainable. This UHC goal remains a work in progress across the region, with a recent World Bank report highlighting limited progress toward UHC in many countries, regional variation in that progress, and key vulnerabilities that must be addressed (22). for example, there are recognized bottlenecks of key human and physical resources (doctors, nurses, hospital beds, medical technologies) that limit an effective healthcare response. The level of government healthcare spending in 2017 stood at 3.8% of GDP across Latin American and the Caribbean, compared to 6.6% among the Organization for Economic Co-operation and Development (OECD) countries (23). Data on quality of care and healthcare inequalities – critical UHC components – remain unavailable for many countries in the Americas.

    Theme 2. Population growth and rapid aging have fueled a rise in the number of deaths

  • The population of the Americas grew from 829 million in 2000 to 1010 million in 2019 – a rise of 22%.
  • The population of the Americas is aging rapidly. Between 2000 and 2019, the proportion aged 40–64 increased from 24% to 29%, and the proportion aged 65 and older increased from 8% to 11%. The proportion of children and younger adults dropped from 68% to 60% (figure 27).
  • These demographic changes have driven a large increase in the absolute number of deaths, despite important mortality rate reductions.
  • Across the six grouped causes of death in this report,14 there were 6.47 million deaths in the Americas in 2019, up from 4.74 million deaths in 2000. This represented a 36.6% increase in deaths.
  • Mortality rate improvements alone (i.e., without population aging or population growth) would have decreased the number of deaths in the Americas by 26%. This potential improvement has been negated by regional population growth that increased deaths by 22%, and by regional population aging that increased deaths by 41%.
  • There was a wide variation between countries in the contribution of mortality rates, population growth, and population aging to the increase in deaths between 2000 and 2019 (figure 28).
  • Trinidad and Tobago reported the smallest percentage increase (5%) in the number of deaths between 2000 and 2019. Mortality rate improvements alone would have decreased the number of deaths by 63%. This potential improvement was negated by regional population growth that increased deaths by 10%, and by regional population aging that increased deaths by 58%.
  • The Dominican Republic reported the largest percentage increase (145%) in the number of deaths between 2000 and 2019. Mortality rate changes alone increased the number of deaths by 57%. This increase was exacerbated by regional population growth that increased deaths by a further 27%, and by regional population aging that increased deaths by a further 61%.
  • The population of the Americas is estimated to grow by a further 17% by 2050, and the proportion of the regional population aged 65 and older is set to more than double by 2050, rising from 11.2%to over 23% (24).
  • Figure 27 presents the age structure for the population of the Americas in 2000 and 2019, with the proportion of men to the left (blue) and the proportion of women to the right (purple). Each horizontal bar represents a five-year age band from 0–4 years upwards, with the topmost bar representing adults aged 85 and older. Adults aged 65 and older are highlighted at the top of each population pyramid. The chart to the right presents the percentage point change in each five-year age group between 2000 and 2019, and shows the increasing proportion of adults from age 45–49 and older. The region is aging, and this trend is predicted to continue for at least the next 30 years. According to estimates from the United Nations, the proportion of the regional population aged 65 and older is set to more than double by 2050, rising from 11.2% to over 23%. The associated decrease in the proportion of younger people means that the old-age dependency ratio – the number of people aged 65 and older for every 100 population aged 15–64 – is set to treble, from 10.5 in 2022 to 29.7 in 2050, with dramatic implications for healthcare financing.

    Figure 28 presents the percentage change in the number of deaths due to NCDs and injuries (as white circles) between 2000 and 2019 for 33 countries of the Americas. The absolute number of deaths have increased in the 20 years since 2000 for every country, and the variation in this increase is large, ranging from a low of 5% in Trinidad and Tobago to a high of 145% in the Dominican Republic. The regional average percentage increase in deaths for the Americas was 37%. There are three contributors to this percentage increase: population growth (purple bars), population aging (orange bars), and changes in age-specific mortality rates (blue bars). For most countries (28 out of 33 countries) improvements in age-specific mortality rates would have led to a decrease in the number of deaths, but this potential decrease was always negated by the additional deaths due to population growth and population aging.

    Future population growth and aging are inevitable demographic features that governments can use to anticipate future healthcare demands. Age-specific mortality rates reflect the health and healthcare environment of individual nations, and over time these rates can be influenced with appropriate national strategies. Across the Americas, improvements in age-specific mortality rates have offset the mortality increase due to population growth and aging by as much as 63% (in Trinidad and Tobago). In the Americas as a whole, a mortality rate improvement of 26% offset the mortality increase due to population growth and aging. The use of mortality rate improvement to control the healthcare implications of population growth and aging will continue to be a key measure in the coming decades.

    Figure 28: Contribution of changes in population growth, population aging, and rates of age-specific deaths to the percentage change in deaths due to noncommunicable diseases and injuries, 2000–2019
    Change due to age-specific mortality rates
    Change due to population aging
    Change due to population growth
    Change in deaths

    Data source:

    Theme 3. There are important mortality rate inequalities across the Region

  • In 2019 there were important inequalities in mortality rates between countries.
  • The five conditions with the largest regional mortality rate inequalities were asthma (IoD 143), drowning (IoD 110), diabetes (IoD 107), prostate cancer (IoD 105), and cervical cancer (IoD 100).
  • The five causes of death with the smallest regional mortality rate inequalities were leukemia (IoD 19), lymphomas (IoD 27), colorectal cancer (IoD 31), pancreatic cancer (IoD 33), and COPD (IoD 34).
  • Countries reporting the lowest mortality rates for a particular condition might offer practical examples of successful strategies for that condition, suggesting a pathway for regional cooperation and mutual learning.
  • Figure 29 presents a summary measure of mortality rate inequality between the 33 countries of the Americas included in this report, for 29 individual causes with associated mortality.15 For each condition, the graphic highlights the size of the between-country inequality. Some of the highest regional mortality rate inequalities are reported for asthma (IoD 143), drowning (IoD 110), diabetes (IoD 107), prostate cancer (IoD 105), and cervical cancer (IoD 100).

    Conditions with high regional mortality rate inequality
  • Diabetes mortality rates varied considerably between countries. Diabetes requires comprehensive and lifelong health care, and national variations in the package of care solutions available may contribute to this inequality.
  • There was high regional inequality in mortality rates due to interpersonal violence and drowning, which require complex intersectoral solutions to enact change. Reducing mortality due to drowning (for example) might include interventions to control access to water hazards, school-based swimming lessons, effective legislation to enforce safe boating, building resilience to flooding through disaster planning and land management, and awareness campaigns on the risks around water including an awareness of sea conditions. Maintaining these complex interventions over time requires sustained cooperation between different sectors of society, and success inevitably varies between countries.
  • There was high regional inequality in mortality rates due to prostate and cervical cancer. For both cancers, variation in the coverage of screening (and for cervical cancer, vaccination) is likely to contribute to these higher inequalities. The United States and Canada, with high screening and vaccination coverage, have rates among the lowest five countries, for example.
  • COPD: chronic obstructive pulmonary disease; HHD: hypertensive heart disease; IHD: ischemic heart disease; RHD: rheumatic heart disease.Data source: World Health Organization. Mortality and global health estimates. Available from: https://www.who.int/data/gho/data/themes/mortality-and-global-health estimates.

  • A high regional inequality was sometimes driven by particularly high rates in a small number of countries. This was the case for drug use disorders – the associated mortality rate in the United States in 2019 was 21.3 deaths per 100 000, almost three times higher than the next highest national rate (Canada, 8.7 deaths per 100 000), and for asthma – where the mortality rate in Haiti (13 deaths per 100 000) was almost three times higher than the next highest rate (Honduras, 5 deaths per 100 000).
  • Large regional inequalities mean that some countries have reported far lower mortality rates for a condition, relative to other countries in the region. Countries reporting lower rates for a particular condition might offer practical examples of successful strategies for a particular disease, suggesting a pathway for regional cooperation and mutual learning. This cooperative dialogue could be key to reducing regional health inequalities.

    Theme 4. Men have had consistently higher rates of death and disability since 2000

  • Fom 33 leading causes of death considered in this report, 30 were conditions affecting women and men. Three cancers primarily affected either women or men alone and were not considered in this section (prostate cancer, cervical cancer, breast cancer).
  • The DALY gender rate ratio (men:women) provides a simple assessment of the relative disease burden among men compared to women. Values above 1 mean a greater burden among men. Values below 1 mean a greater disease burden among women.
  • In 2019 men had higher rates of mortality and disability for 23 of the 30 conditions.
  • Among the cardiovascular diseases, men had a greater disease burden for four of the five conditions (ratio between 1.14 and 2.03).
  • Among the cancers, men had a greater disease burden for all conditions (ratio between 1.31 and 1.80).
  • Among respiratory diseases, men had a higher burden of COPD (ratio 1.21) while women had a higher burden of asthma (ratio 0.84).
  • For diabetes the burden was higher among men (ratio 1.21).
  • Among the mental and substance use disorders, men had a higher burden of alcohol use disorders (ratio 2.87), drug use disorders (ratio 1.58), and schizophrenia (ratio 1.09), while women had a higher burden of depressive disorders (ratio 0.55) and anxiety disorders (ratio 0.57).
  • Among the neurological conditions, men had a higher burden of Parkinson disease (ratio 2.06) and epilepsy (ratio 1.15) while women had a higher burden of migraines (ratio 0.49), non-migraine headaches (ratio 0.77), and Alzheimer disease and other dementias (ratio 0.89).
  • Among injuries, men had a higher burden of all leading causes, with a gender ratio of 6.51 for interpersonal violence, 3.74 for drowning, 3.23 for self-harm, 3.17 for road injuries, and 1.45 for falls.
  • Figure 30 presents the DALY gender rate ratio (men:women) for 30 conditions affecting women and men. Three cancers primarily affected either women or men alone and were not considered in this section (prostate cancer, cervical cancer, breast cancer). The graphic provides a simple assessment of the relative disease burden among men compared to women in 2019. Values above 1 mean a greater burden among men. Values below 1 mean a greater disease burden among women.

    Note: Bars to the right mean a higher DALY rate in men; bars to the left mean a higher rate among women.

    Data source:

    There was a particularly high male burden due to interpersonal violence, with the DALY gender rate ratio in 2019 of 6.51 and a mortality gender rate ratio of 7.16. This excess has been consistent in the 20 years since 2000 – always 7 deaths among men for every female death. Although this male excess is unequivocal, interpersonal violence is a broad categorization, and further information is needed to tease out the complex and disparate patterns of violence across the region. Globally, men are more likely to die from violence (especially community violence), while women are more likely to experience non-fatal violence with severe and often long-term consequences for their mental, physical, sexual, and reproductive health and well-being. Further classification, for example, introduces a typology that identifies the perpetrator (such as family, partner, acquaintance or stranger) and the nature of the violence (physical, sexual, psychological, deprivation or neglect) (25). Within this broad classification there will be interpersonal violence types – such as domestic violence – where women suffer greater victimization. Improved injury surveillance and targeted research are urgently needed.

    Mental health and substance use disorders present a complex picture, with a greater male burden of alcohol and drug use disorders, and a greater female burden of anxiety and depressive disorders. Many mental health disorders can be diagnosed and treated cost-effectively, and there is a growing recognition of the need for comprehensive mental health services to be offered as part of a universal health coverage (UHC) package (26). The Caracas Declaration in 1990 laid the foundation for community mental health services for the Americas, but progress across the region has been uneven (27).

    Diabetes affected men more than women in 2019, but this was not always the case, with the DALY gender ratio at parity in 2000. The worsening outcomes among men relative to women come against a backdrop of a near stationary diabetes mortality rate (a 5% drop in the regional rate between 2000 and 2019) and a rising disability rate (the regional DALY rate rose by 17% between 2000 and 2019). The comprehensive care required for people living with diabetes involves daily self-management and regular contact with primary care, and the tendency of men to seek health care less regularly than women may contribute to this evolving gender inequality (28).

    Theme 5. The Caribbean subregions are disproportionately affected by cardiovascular disease, cancers, and diabetes

  • In 2019, the two Caribbean subregions (Latin Caribbean, non-Latin Caribbean) reported markedly higher CVD, cancer, and diabetes DALY rates compared to the rest of the Americas.
  • Eight leading disease risk factors in the Americas raise the risk of CVD, diabetes, and many cancers.
  • In the Caribbean and Central America, six out of these eight leading risk factors are increasing in importance. This compares to no more than two from eight in the rest of the Americas.
  • There are a range of public health policies recognized internationally as cost-effective strategies to limit the burden of NCD risk factors and disease. Progress toward implementing these strategies is now tracked by WHO.
  • In the Americas, the Caribbean in particular has made limited and uneven progress toward implementing these public health strategies.
  • Figure 31 presents the distribution of DALY rates for 33 countries of the Americas grouped into two broad subregions: the Caribbean (Latin Caribbean and non-Latin Caribbean combined) and the rest of the Americas. The distributions are provided for three groups of conditions (CVD, cancers, and diabetes), with the median DALY rate (white line) provided for each region. The two Caribbean subregions in 2019 reported noticeably higher rates of mortality and disease burden for these three groups of conditions. for CVD, 9 out of the 10 highest disability (DALY) rates were among Caribbean countries. For cancers, 8 out of the 10 highest disability rates were among Caribbean countries. For diabetes, 8 out of the 10 highest disability rates were among Caribbean countries.

    CVD, diabetes, and many cancers are influenced by a similar group of lifestyle risk factors, including lack of physical activity, poor nutrition, tobacco use, and excessive alcohol use. Over time, these behaviors can lead to overweight and obesity, high blood pressure, and high cholesterol. The Global Burden of Disease (GBD) has quantified estimated health loss (DALYs) from hundreds of diseases and injuries for all regions of the world. In a recent publication, the GBD study highlighted risk factors contributing to disease burden across the world (29). There were eight leading risk factors common to all subregions of the Americas (for the GBD Study, the Americas was subdivided into five subregions: Caribbean, Central America, High-income North America, Southern Latin America, Tropical Latin America). Each of these eight risk factors influences the NCD burden, and they are shown in figure 32, ranked by order of importance16 in each subregion (1 to 8). Between subregions, the same risk factor is joined by a gray line. From these eight risk factors, high fasting plasma glucose, high systolic blood pressure, and high body mass index were in the top four contributors for every subregion. Risk factors that increased markedly in importance between 2010 and 2019 (an annual increase in attributable risk above 1.6%) are highlighted as red circles. The Caribbean and Central America subregions each had six of eight risk factors with a marked increase in importance, including the same leading three factors: high fasting plasma glucose, high systolic blood pressure, and high body mass index.

    In the face of increasing numbers of deaths and DALYs (see Theme 2) and an increasingly prevalent risk factor burden, public health interventions offer critical pathways for NCD control. WHO in 2020 published a report on progress toward implementing a set of public health “best buy” interventions to prevent and control NCDs (30), with progress tracked using 19 indicators (31). figure 33 presents the progress of each country in the Americas toward implementing these best buy interventions (not implemented, partially implemented, fully implemented). The countries in the chart are ordered using an informal policy progress summary score (0 points for not implemented, 1 point for partially implemented, 2 points for fully implemented, for a total score between 0 and 38 points). National scores ranged from 30 (Chile) to 3 (Haiti). Of the 33 included countries, the top 17 countries (progress scores from 33 to 17) included just 1 Caribbean nation (Guyana). The bottom 16 countries (progress scores from 16 to 2) included 12 Caribbean nations.

    A note on COVID-19

    The Americas was severely affected by COVID-19, with profound implications for future health. This report has drawn primarily on the 2019 edition of the WHO Global Health Estimates (GHE), which presents comprehensive and comparable health-related indicators from 2000 to 2019. The 2019 edition was released before the COVID-19 pandemic took hold across the world, and before its far-reaching social and economic consequences could have been imagined.

    The pandemic was a health crisis, but it affected all aspects of our societies. Businesses were hit hard, losing working hours that amounted to 255 million full-time jobs in 2020 (32). Working hour losses were particularly high in Latin America and the Caribbean, reflecting the stringent lockdown measures across the region. Economically, women and young adults were hardest hit because of the sectors most affected by the pandemic: food, hospitality and tourism, health, and social care. School closures shifted care responsibilities to the home, with this additional burden more regularly falling on women. Whether through job losses or school closures, the pandemic reversed real progress on gender equality (33).

    All economies were affected, and the wealthiest countries provided extensive social support to workers and the general population, injecting USD 9.8 trillion into their economies (from a global total of USD 11.7 trillion) (34). These support mechanisms were not possible among most low- and middle-income countries, which had fewer resources to counteract the health and economic burden of the pandemic. Health system frailties were laid bare, with shortages of health workers, hospital beds, and medical technologies.

    The absolute numbers of deaths across the region exceeded 2.7 million by April 2022 (the first confirmed death in the Americas was in the United States on 29 February 2020), against a backdrop of 7.61 million deaths from all-causes in 2019. The effect of COVID-19 on future mortality and disease burden estimates will be profound, but to arrive at comparable estimates of mortality and disease burden for different countries and over time will inevitably require estimation for the many locations without detailed information, for example on excess mortality 17 related to the pandemic. The next Global Health Estimates update will include an assessment of the direct and indirect impact of the COVID-19 pandemic on mortality and morbidity.

    Footnotes

    13 Four causes had either no associated mortality or very low mortality: depressive disorders, anxiety disorders, migraines, and non-migraine headaches

    14 The six grouped causes of death were cardiovascular diseases, cancers, respiratory diseases, diabetes, mental and substance use disorders and neurological conditions, and external causes.

    15 Four causes had either no associated mortality or very low mortality: depressive disorders, anxiety disorders, migraines, and non-migraine headaches.

    16 Figure 32 presents eight common NCD risk factors across the Americas. Risk factors are ranked according to their relative contribution (attributable risk) to DALYs. A red circle means that the risk factor increased markedly in importance between 2010 and 2019 (defined as an annual increase in attributable risk between 1.6% and 5%).

    17 Excess mortality refers to the number of deaths from all causes during a crisis over and above “normal” conditions. This quantity cannot be directly observed but can be estimated in several ways. Excess mortality is a more comprehensive measure of the total impact of the pandemic on deaths than the confirmed COVID-19 death count alone. It captures not only the confirmed deaths but also COVID-19 deaths that were not correctly diagnosed and reported, as well as deaths from other causes that are attributable to the overall crisis conditions.